Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kegyes

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancers|September 28, 2024
MRD in Acute Leukemias: Lessons Learned from Acute Promyelocytic LeukemiaDavid Kegyes, Praveena S Thiagarajan, Gabriel Ghiaur
Journal of Clinical Medicine|September 28, 2023
Outcomes of CAR-T Cell Therapy Recipients Admitted to the ICU: In Search for a Standard of Care-A Brief Overview and Meta-Analysis of ProportionsCatalin Constantinescu, Vlad Moisoiu, Bogdan Tigu, et al.
Critical Reviews in Oncology/Hematology|March 4, 2024
Immune therapies of B-cell acute lymphoblastic leukaemia in children and adultsDavid Kegyes, Gabriel Ghiaur, Anamaria Bancos, et al.
Blood Reviews|February 2, 2023
Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemiaDavid Kegyes, Ciprian Jitaru, Gabriel Ghiaur, et al.
Journal of Cellular and Molecular Medicine|September 10, 2024
A hypothesis on treatment strategy of severe multicentric Castleman disease with continuous renal replacement therapyCătălin Constantinescu, David Kegyes, Bogdan Tigu, et al.
Blood Reviews|December 14, 2024
Neuro-toxicities of chemo- and immune-therapies in haematologic malignancies: from mechanism to managementDavid Kegyes, Vlad Moisoiu, Catalin Constantinescu, et al.
Signal Transduction and Targeted Therapy|August 13, 2024
Therapeutic advances of targeting receptor tyrosine kinases in cancerCiprian Tomuleasa, Adrian-Bogdan Tigu, Raluca Munteanu, et al.
Journal of Personalized Medicine|December 27, 2022
COVID-19 Impact on Chronic Myeloid Leukemia PatientsDana Raluca Arbore, Simona Maria Galdean, Delia Dima, et al.
Cell Death Discovery|November 17, 2024
Therapeutic advances in the targeting of ROR1 in hematological cancersAdrian-Bogdan Tigu, Raluca Munteanu, Cristian Moldovan, et al.
Expert Opinion on Therapeutic Targets|September 5, 2024
Looking ahead to targeting macrophages by CAR T- or NK-cells in blood cancersDavid Kegyes, Paul Alexandru Milea, Andreea-Isabella Mazga, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancers|September 28, 2024
MRD in Acute Leukemias: Lessons Learned from Acute Promyelocytic LeukemiaDavid Kegyes, Praveena S Thiagarajan, Gabriel Ghiaur
Journal of Clinical Medicine|September 28, 2023
Outcomes of CAR-T Cell Therapy Recipients Admitted to the ICU: In Search for a Standard of Care-A Brief Overview and Meta-Analysis of ProportionsCatalin Constantinescu, Vlad Moisoiu, Bogdan Tigu, et al.
Critical Reviews in Oncology/Hematology|March 4, 2024
Immune therapies of B-cell acute lymphoblastic leukaemia in children and adultsDavid Kegyes, Gabriel Ghiaur, Anamaria Bancos, et al.
Blood Reviews|February 2, 2023
Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemiaDavid Kegyes, Ciprian Jitaru, Gabriel Ghiaur, et al.
Journal of Cellular and Molecular Medicine|September 10, 2024
A hypothesis on treatment strategy of severe multicentric Castleman disease with continuous renal replacement therapyCătălin Constantinescu, David Kegyes, Bogdan Tigu, et al.
Blood Reviews|December 14, 2024
Neuro-toxicities of chemo- and immune-therapies in haematologic malignancies: from mechanism to managementDavid Kegyes, Vlad Moisoiu, Catalin Constantinescu, et al.
Signal Transduction and Targeted Therapy|August 13, 2024
Therapeutic advances of targeting receptor tyrosine kinases in cancerCiprian Tomuleasa, Adrian-Bogdan Tigu, Raluca Munteanu, et al.
Journal of Personalized Medicine|December 27, 2022
COVID-19 Impact on Chronic Myeloid Leukemia PatientsDana Raluca Arbore, Simona Maria Galdean, Delia Dima, et al.
Cell Death Discovery|November 17, 2024
Therapeutic advances in the targeting of ROR1 in hematological cancersAdrian-Bogdan Tigu, Raluca Munteanu, Cristian Moldovan, et al.
Expert Opinion on Therapeutic Targets|September 5, 2024
Looking ahead to targeting macrophages by CAR T- or NK-cells in blood cancersDavid Kegyes, Paul Alexandru Milea, Andreea-Isabella Mazga, et al.
Pageof 3